POSTBIOTIC IMPACT ON HOST METABOLISM AND IMMUNITY PROVIDES THERAPEUTIC POTENTIAL IN METABOLIC DISEASE

Descargar Publicación
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial Un nuevo procedimiento combinado con semaglutida podría eliminar la dependencia de insulina en la diabetes tipo 2